Marrow Protection: Transduction of Hematopoietic Cells with Drug Resistance Genes -

Transfer of Drug Resistance Genes into Hematopoietic Stem.

Aug 22, 2002 · Serial transplants demonstrated protection in secondary recipients and confirmed the transduction of transplantable stem cells. Thus, these data. The ability of the MDR1 gene to protect hematopoietic cells from the myelotoxicity of anticancer drugs was determined by reconstituting patients with gene-modified CD34cells, one half of which were transduced with a retroviral vector containing the MDR1 multidrug resistance gene G1MD, while the other half were transduced with a retroviral vector containing the neomycin resistance NeoR gene. Bone Marrow Cell Dihydrofolate Reductase Autologous Bone Marrow Transplantation Drug Resistance Genes Murine Bone Marrow Cell These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves. This study was undertaken to analyze the hematotoxicity of paclitaxel Taxol® and to test whether transduction of repopulating hematopoietic cells with a retroviral vector SF1m expressing the human multidrug resistance 1 gene MDR1 would permit dose intensification following bone marrow transplantation BMT.While the regimen chosen 8×20 mg/kg i.p. within 12 days produced a non. The generation of high titer retroviral vectors permits transduction of stem cells with a variety of genes and leads to long-term marking in the blood of recipient mice. Optimized promoter/enhancers facilitate high-level transgene expression in mice transplanted with transduced bone marrow BM cells.

Tulin Budak-Alpdogan, Debabrata Banerjee and Joseph R Bertino, Hematopoietic stem cell gene therapy with drug resistance genes: an update, Cancer Gene Therapy, 10.1038/sj.cgt.7700866, 12, 11, 849-863, 2005. Drug Resistance of Normal Hematopoietic Stem Cells Jan Moreb, M.D., and James R. Zucali, Ph.D. We have previously shown that preincubation with interleukin-1 IL-1 and tumor necrosis factor alpha TNFa can protect normal hematopoietic progenitors but not leukemic cells from the toxicity of 4-hydroperoxy-cyclophosphamide 4-HC, an active derivative of cyclophosphamide.

Get this from a library! Marrow protection: transduction of hematopoietic cells with drug resistance genes. augmentation of methotrexate resistance with co-expression of metabolically related genes; protection of bone marrow cells from toxicity of chemotherapeutic agents targeted toward thymidylate synthase by transfer of mutant forms of. ISBN: 3805568282 9783805568289: OCLC Number: 41137560: Description: vii, 184 pages: illustrations; 25 cm. Contents: Basic Principles of Gene Transfer in Hematopoietic Stem Cells / M. Sadelain, C. May and S. Rivella / [and others] --Optimizing Conditions for Gene Transfer into Human Hematopoietic Cells / M.A.S. Moore and K.L. MacKenzie --Transfer of the MDR-1 Gene into Hematopoietic Cells / A. bone marrow would be the combination of one or more drug resistance genes with MDRl for the protection of hematopoietic precursors against the toxic effects of several families of anticancer drugs. One such class of drug resistance genes is the glutathione transferase family 16. Members of this family of cnzmcs including the TT.«,and. Marg Pena,1 Erin Morrey,2 H. Trent Spencer.2. Transduced hematopoietic stem cells have stably engrafted and differentiated into myeloid cells containing ADA mean range at 1 year in bone marrow lineages, 3.5 to 8.9% and lymphoid cells.

This study reports efficient transduction of human CD34cells with a drug resistance gene allowing post-transduction selection using lentivirus under low-MOI conditions that did not require cytokine stimulation or viral concen- tration. Marrow protection - transduction of hematopoietic cells with drug resistance genes. Cytotherapy. 2001;32:67–84. Article CAS PubMed Google Scholar. Request PDF On Nov 1, 2008, Joseph R Bertino published Transfer of Drug Resistance Genes into Hematopoietic Stem Cells for Marrow Protection Find, read and cite all the research you need on. Resistance is not mediated through increased drug efflux or metabolism, but is shown to emerge from leukaemia stem cells both ex vivo and in vivo. Chromatin-bound BRD4 is globally reduced in resistant cells, whereas the expression of key target genes such as Myc remains unaltered, highlighting the existence of alternative mechanisms to regulate. Transgenic overexpression of chemotherapy resistance CTX-R genes in hematopoietic stem- and progenitor cells, also referred to as chemo- or myeloprotective gene therapy, represents a potential strategy to overcome this problem [1, 2].

Marrow Protection: Transduction of Hematopoietic Cells with Drug Resistance Genes

Utilization of chemotherapy for treatment of tumors is mainly limited by its hematological toxicity. Because of the low level expression of drug resistance genes, transduction of hematopoietic progenitors with multidrug resistance 1 MDR1 or multidrug resistance-associated protein 1 MRP1 genes should provide protection from chemotherapy toxicity. Because of the low level expression of drug resistance genes, transduction of hematopoietic progenitors with multidrug resistance 1 MDR1 or multidrug resistance-associated protein 1 MRP1 genes should provide protection from chemotherapy toxicity. that overexpression of the multidrug resistance gene MDR1 in murine bone marrow cells results in protection from hemato-poietic toxicity from chemotherapy drugs that are substrates for the MDR1 drug efflux pump 7–9. Subsequent studies in mice reconstituted with hematopoietic cells. Successful transfer of drug resistance genes into hematopoietic cells may allow the administration of higher doses of chemotherapy and, thus, increase regression of chemosensitive tumors. The interest in the use of MRP as an alternative to MDR1 for bone marrow protection lies. Drug-resistant variants of DHFR have been expressed in human umbilical cord blood CD34cells after gammaretroviral vector transduction. 39,40 However, in clinical trials to treat X-linked severe combined immunodeficiency by transduction of hematopoietic cells with gammaretroviral vectors, genotoxicity was observed. 41 Although deep sequencing.

Hematoprotection and enrichment of transduced cells in.

To protect bone marrow cells from the toxicity of chemotherapy, a multidrug resistant gene or a dihydrofolate reductase gene has been introduced into stem cells. These genes, however, are not capable of conferring refractoriness to alkylating agents AA, which are some of the most commonly used agents in chemotherapy regimens. INTRODUCTION. Hematopoietic stem cell transplantation HSCT is a mainstay of treatment for hereditary disorders and lymphohematopoietic malignancies, and is the most commonly employed modality for ex vivo gene therapy. However, this procedure often entails myeloablative conditioning by irradiation and/or cytotoxic drugs which incur significant morbidity [1, 2], and low engraftment rates. MGMT with O6-benzylguanine 6-BG and protection of sensitive tissues, such as hematopoietic stem and progenitor cells, using genetic modifica-tion with 6-BG-resistant MGMT mutants. We have used retroviral-medi-ated gene transfer to transduce murine hematopoietic bone marrow cells with MGMT point mutants showing resistance to 6-BG depletionin. Finally, because of the rapid advancements in gene-editing techniques, correction of CD34cells isolated from patients with FA is now feasible, using gene-targeting strategies. Taken together, these advances indicate that gene therapy can soon be used as an efficient and safe alternative for the hematopoietic treatment of patients with FA.

Methodology of Clinical Drug Trials P. Simon
Pathobiologie Oraler Strukturen: Zaehne, Pulpa, Parodont Hubert E. Schroeder
Theilheimer's Synthetic Methods of Organic Chemistry, Vol. 52 (1997)
The Scientific Basis of Eating: Taste, Smell, Mastication, Salivation and Swallowing and Their Dysfunctions (Frontiers of Oral Biology, Vol. 9)
International Society of Blood Purification: 13th Annual Meeting, Kyongju/Korea, September 1995: Abstracts
The Thyroid: Fine-Needle Biopsy and Cytological Diagnosis of Thyroid Lesions (Monographs in Clinical Cytology, Vol. 14)
Respiratory Immune Defense in Children: Current Knowledge and Possible Therapeutic Interventions: Satellite Symposium of the 1st International ... : Respiration, Vol. 61, Supplement1, 1994)
Pathophysiology of Lipid Peroxides and Related Free Radicals: International Symposium, Inuyama, November 1996
Dialysis Membranes: Structure and Predictions: International Workshop, Marseille, June 1994 (Contributions to Nephrology, Vol. 113)
Viruses and Virus-Like Agents in Disease: A Karger Symposium, Basel, March 1993 (Intervirology)
Mechanisms of Renal Injury and Repair (Mineral and Electrolyte Metabolism, Vol 21, No 4-5 1995)
Pancreatic Diseases: New Horizons: International Meeting, Bern, September 1994 (Digestive Surgery, Vol 11, No 3-6 1994)
Carvedilol - A Wide Therapeutic Potential in Cardiovascular Syndromes: Satellite Symposium organized by the International Cardiological Institute for ... (Cardiology, Vol 82, Supplement 3, 1993)
Urinary Tract Cancer: State of the Art: EORTC Data Center, Brussels, November 1995 (European Urology)
Xxviies Journees Nationales De Neonatologie 1997 (French Edition)
Hypusine Formation on Eukaryotic Initiation Factor 5A: Biochemistry and Function (Biological Signals Ser. Series, 3)
Modulation of the Immune Response to Vaccine Antigens: Symposium organized and sponsored by the University of Bergen and the International Association ... 1996 (Developments in Biologicals, Vol. 92)
Precursors of Prostatic Adenocarcinoma: Recent Findings and New Concepts (Journal : European Urology, Vol. 30, No. 2, 1996) Rodolfo Montironi
Clinical Paediatric Endocrinology: Serono Symposia Workshop, Arles September 1997 (Hormone Research)
A Model Quality System for the Transfusion Service
Interface - International Forum for Action in Cardiovascular Education: Amsterdam, November 1993: Proceedings (Cardiology)
Prostate Cancer: Hormonal Treatment and Treatment of Advanced Disease: 4th International Symposium on Recent Advances in Urological Cancer Diagnosis ... June 1994: Proceedings (European Urology)
Porzellan bemalen mit Uwe Geißler. Von seinen Anfängen in Meissen bis zur freien Malschule. Uwe Geißler
Botany of Captain Beecheys Voyage G A Walker- Arnott William J Hooker
Ministranten Wandkalender 2009 Unknown.
Grenzen der Sozialdisziplinierung: Aufstieg und Krise der deutschen Jugendfursorge von 1878 bis 1932 (German Edition) Detlev Peukert
Das zweite Buch von den Konigen (Die Botschaft des Alten Testaments) (German Edition) Klaus Dietrich Fricke
Fetish and Fashion: The Most Exciting Images of the Very Different Kind of Fashion (German Edition)
Through the Painter's Eye: Locating Art in Europe Florian Heine
Richard Oelze: Ein alter Meister der Moderne (German Edition) Renate Wiehager
Best of Black and White: Erotic Photography Siri And Gisbourne Hustvedt
The Earth as Art: Views from Heaven Klaus D. Francke
Forest Planet: The Last Green Paradises (Greenpeace Books)
Sportbootkarten Satz 7/2003. Balearen. Mallorca - Ibiza - Menorca - Formentera.
Die Worte haben es schwer mit uns: Der P.E.N. in Erlangen 1984 (Texte zur Zeit) (German Edition)
Darmstadt: 1945-heute (German Edition) Margarete Dierks
Laboulbeniales Isabelle I. Tavares
Pathogenesis, Diagnosis and Clinical Relevance of Pleural Plaques: International Meeting, Basel, January 1997 (Indoor & Built Environment Ser. 2)
Measurements of Acute Stroke Events an Outcome: Present Practice and Future Hope: 6th European Stroke Conference, Plenary Session, Amsterdam, May 1997 (Cerebrovascular Disease)
sitemap 0
sitemap 1
sitemap 2
sitemap 3
sitemap 4
sitemap 5
sitemap 6
sitemap 7
sitemap 8
sitemap 9
sitemap 10
sitemap 11
sitemap 12
sitemap 13
sitemap 14
sitemap 15
sitemap 16
sitemap 17
sitemap 18